Most of the currently used antidepressants work by blocking the reuptake of serotonin (5-HT) and norepinephrine (NE), two monoamines impaired in mood disorders. Due to their suboptimal clinical efficacy and adverse effects, it is critical to investigate alternative targets for the development of novel antidepressants. One promising candidate is the melatonergic system, involved in many physiological processes, including sleep, and mood. It exerts its effects mainly by activating its receptors, MT1 and MT2. Due to the lack of studies employing selective MT1 or MT2 ligands and/or knockout mice, the potential antidepressant effects of MT1 and MT2 are poorly understood. We studied the role of MT1 in depression with MT1-knockout mice (MT1KO) in behavioural tests, HPLC-ECD analysis of whole brain levels of monoamines and their metabolites, and in vivo electrophysiology of 5-HT firing in the dorsal raphe nucleus (DRN). Moreover, using the novel selective MT1 partial agonist UCM871, we examined its effects on 5-HT firing in rats. Behavioural studies revealed that MT1 (but not MT2) is involved in depression; DRN 5-HT firing rate is not significantly altered in MT1KO mice, but they display a lower percentage of bursting neurons; the level of 5-HIAA (5-HT metabolite) is higher in MT1KO than in WT. Remarkably, acute administration of UCM871 had a dose-dependent excitatory effect on 5-HT DRN firing. Altogether, these results validate MT1 as a novel target for the development of alternative antidepressants. Background: Functional recovery remains the primary goal following treatment of a psychotic disorder, especially after a first episode. Evidence regarding relative contributions of predictors of functional outcome, including symptoms and cognition, remains equivocal. Objective: We tested the relative roles of remission and cognition as predictors of functioning while controlling for established predictors of functioning in a large first-episode psychosis (FEP) sample. Methods: Established predictors (DUP, medication adherence, age of onset, substance use, premorbid adjustment), verbal memory and length of positive and negative symptom remission were regressed on functioning at 1 (n =208) and 2 (n=159) years. Regressions were conducted with established predictors in the first step, followed by verbal memory and consecutive months of combined positive and negative symptom remission in the third step. Regressions were then repeated with length of positive and negative symptom remission, respectively. Results: Length of combined positive and negative symptom remission explained the most variance in functioning at 1 (R² adj =.35, F(9,129)=9.33, p <.001) and 2 (R² adj = .38 F(9,97)=8.21, p <.001) years, and verbal memory contributed only slightly to such outcome. While length of remission of negative symptoms was a stronger predictor of functioning than remission of positive symptoms at 1 year, length of positive remission made a large contribution at two years as well. Conclusions: These results highlight the importance of achieving and maintaining remission of both negative and positive symptoms for longer periods in FEP patients and the need for effective interventions to do so.
Background
Hippocampal neurogenesis has been implicated in the mechanism of antidepressant action, and neurotrophic factors can mediate neurogenic changes underlying these effects. The neurotrophic factor neuregulin-1 (NRG1) is involved in many aspects of brain development. However, little is known about the influence of NRG1 on neurodevelopmental processes in the mature hippocampus.
Objective
These experiments examine the potential role of NRG1-ErbB signaling in hippocampal neurogenesis, affective behaviour, and psychopathology.
Methods
Adult mice were given subcutaneous NRG1 or saline to assess dentate gyrus (DG) proliferation, survival, differentiation, morphology, and neurogenesis, and underwent behavioral testing. Expression of NRG1 receptors in newborn DG cells was assessed at various time points. ErbBexpressing progenitor cell phenotype was characterized. DG dissections were used for ELISA. We extended these findings into psychiatrically-relevant human subjects, examining hippocampal NRG1/ErbB gene expression and methylation in suicide completers and controls. Results Subchronic peripheral NRG1β administration selectively increased cell proliferation and neurogenesis (but not survival, differentiation, or immature neuronal morphology) in the ventral DG. These effects may have been mediated by ErbB3 receptors, expressed by newborn cells from division to maturity and colocalized with SOX2 in the subgranular zone. NRG1 increased ventral DG ErbB3 phosphorylation. Four weeks (but not acutely) after treatment, animals displayed antidepressant-like behavior. In humans, hippocampal ErbB3 expression was reduced in suicides, which was not due to ErbB3 methylation, although antidepressants induced methylation changes. Conclusions NRG1β has pro-proliferative, neurogenic, and antidepressant properties, potentially through NRG1-ErbB3 signaling, and human psychiatrically-relevant subjects show reduced hippocampal ErbB3 expression. This highlights the importance of peripheral neurotrophic factors in neurogenesis and mood, supports hippocampal neurogenesis as a mediator of antidepressant effects, and suggests a potential role of hippocampal NRG1-ErbB3 signaling in suicidality.
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Manipulating the Sense of Agency with Magic
Jay Olson, Alym Amlani, Amir Raz, Ronald Rensink
RAZ LAB, DEPARTMENT OF PSYCHIATRY, MCGILL (J.O. & A.R.); VISUAL COGNITION LAB, DEPARTMENT OF PSYCHOLOGY, UNIVERSITY OF BRITISH COLUMBIA (A.A. & R. R.)
Background. A common symptom of schizophrenia is alien control or a distorted sense of agency: thoughts and actions appear to originate from a source other than one's own will. Scientists do not understand how these distortions occur. Studying similar distortions in the non-clinical population could help shed light on the mechanism underlying the sense of agency and suggest new options for treatment.
Objective. Magicians often distort the sense of agency in their audiences. Specifically, forcing occurs when a magician influences the audience's decisions while they retain a full sense of agency. For example, an audience member may feel as if she is freely choosing a playing card, though the magician is controlling the choice. We investigated the rate and predictors of forcing in order to distort the sense of agency and probe its mechanism.
Methods and Results.
In Study 1, a magician approached 108 people on the street and flipped through a deck of playing cards while each person chose a card. By making one card appear more salient, the magician could influence almost everyone (98%) to choose that card yet few (9%) noticed the influence. In Study 2, 43 participants observed rapid series of 26 cards shown on a computer. In each of the 28 trials, one target card was made more salient by showing it slightly longer than the rest. Participants chose the target card on 30% of the trials yet many (40%) were unaware of the influence. Among this unaware group, locus of control weakly predicted choice; people who believed they had more control over their lives were harder to influence. Among the aware group, stimulus factors such as the memorability of the card predicted choice; people chose more memorable cards. Studying this paradigm of forcing has demonstrated a robust method of distorting the sense of agency during simple decisions. Future research can explore how such distortions relate to disorders of mental control in order to better understand their symptoms and treatment. Initiation of drug use during adolescence is a strong predictor of both the incidence and severity of lifetime drug abuse. Intriguingly, adolescence is also a period of dynamic refinement to the organization of neuronal connectivity, in particular dopamine circuitry. The enduring behavioral effects of adolescent drug exposure may therefore result from disruption in dopamine development. In this study we investigated (a) the effects of repeated exposure to amphetamine during adolescence on behavioral sensitization, conditioned locomotor activity, and organization of dopamine circuitry in adulthood; (b) we compare these effects to those induced by an identical amphetamine regimen administered in adulthood. We treated early adolescent (PND 21±1) and adult (PND 75±15) male C57/BL6 mice with i.p. injections of amphetamine (4 mg/kg) or saline.
Mice received one injection every other day for a total of 5 days. Behavioral sensitization and conditioned locomotor activity were evaluated 6 weeks after the last pretreatment dose for both adolescent and adult pretreated groups. This delay allowed adolescent-pretreated mice to reach adulthood; adult-pretreated mice were matched to the same interval. We then assessed dopamine connectivity in the medial prefrontal cortex and nucleus accumbens. We found that mice that received amphetamine treatment either in adolescence or in adulthood show conditioned locomotor activity when re-exposed to the previously drug paired chamber. Importantly, this conditioned response was exaggerated in adult mice that received drug treatment during adolescence. Stereological analysis of the expanse and number of dopamine varicosities revealed that amphetamine exposure during adolescence, but not in adulthood, leads to an increase in the volume that dopamine axons occupy in the medial prefrontal cortex, but that these axons are "denuded" from presynaptic sites. This effect appears to be selective to the medial prefrontal cortex because we did not find changes in dopamine innervation in the nucleus accumbens. These findings show that amphetamine in adolescence alters the development of the dopamine input to the medial prefrontal cortex, reducing dramatically dopamine synaptic connectivity, and alters conditioned locomotor response. Remarkably, our most recent results show that the effects of adolescent amphetamine exposure on medial prefrontal cortex development are mediated by DCC signaling within dopamine neurons. Objective: To determine whether in utero exposure to disaster-related PNMS is associated with altered hippocampal volumes in 11½ year-old children. We hypothesized that higher maternal objective or subjective PNMS levels would be related to smaller hippocampal volumes.
Methods: Measures of maternal objective (i.e., events the women experienced) and subjective (i.e., the women's psychological response to the crisis) PNMS were obtained after the 1998 Quebec Ice Storm. We obtained T1-weighted images of 33 males and 32 female 11½ year olds. Hippocampal segmentations from native MRI scans were performed using the automatic SACHA method. The number of obstetric complications was recorded using hospital records.
Results:
Overall, more obstetric complications were related to smaller hippocampal volumes in both male and females. Higher levels of maternal objective stress were related to smaller right hippocampal volumes (RHCV) in males only. Objective stress and obstetric complications and their interaction term accounted for 34.6% of the variance of the male's RHCV. Inspection of the objective stress × obstetric complication interaction revealed that males exposed to high levels of objective stress or obstetric complication or both had smaller RHCV compared to males exposed to low levels of objective stress and obstetric complications.
Conclusions:
Our results suggest that higher levels of disaster-related objective stress, but not subjective distress are related to smaller RHCV in male but not female children. It remains to be determined whether this alteration in RHCV of 11.5 years old males is related to observable phenotypes.
March of Dimes foundation and the Canadian Institutes of Health Research.
Effect of TNF-alpha inhibition in a prodromal model of Alzheimer's disease
Chelsea Cavanagh, Remi Quirion & Tak Pan Wong
WONG LAB, DOUGLAS HOSPITAL RESEARCH CENTRE
Background: Alzheimer's disease (AD) develops decades before clinical symptoms arise and can remain undiagnosed for years. For this reason, there is a need to intervene before the development of cognitive symptoms. One possible culprit in the development of AD is tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory cytokine. TNF-alpha is upregulated in both humans with AD and transgenic models of the disease. TNF-alpha is a well-known immune mediator and is recognized as a modulator of learning, memory, and synaptic function. The role of TNF-alpha in synaptic function is thought to be regulatory at physiological levels, but neurotoxic when found in excess. Since proper synaptic function underlies healthy cognitive processing, it is critical to understand the effect of TNF-alpha on synaptic function in AD. Consequently, the early intervention of TNF-alpha signaling may help prevent the detrimental effects of excess TNF-alpha on synaptic function. We hypothesize that increased levels of TNF-alpha at early stages of AD-like pathology may become pathogenic and lead to deficiencies in synaptic function. Objective: To advance the current understanding of TNF-alpha signaling as it relates to synaptic pathology in the early stages of AD. Methods: We used 1-month-old TgCRND8 mice, which harbor a mutated form of the amyloid precursor protein (APP), the precursor to amyloid-beta, to study synaptic function in acute hippocampal slices using electrophysiological field recordings. Levels of TNF-alpha and amyloid-beta were measured by enzyme-linked immunosorbent assays. Results: We found that TNFalpha is significantly increased in hippocampal tissue from 1-month-old TgCRND8 mice. These mice also displayed an increased post-synaptic response relative to a given pre-synaptic input compared to control mice. This increase in synaptic output could be attenuated using a TNF-alpha inhibitor. Notably, these alterations were present before the overproduction of amyloid-beta. Conclusion: Our findings provide insight on TNF-alpha as a potential therapeutic target in the prodromal stages of AD and help elucidate the effects of TNF-alpha on synaptic function. Inhibiting TNF-alpha at early stages of the disease could be a novel therapeutic approach to prevent synaptic pathology and consequent memory deficits in AD.
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The longitudinal effects of neighborhood social and material deprivation change on psychological distress in urban, community-dwelling Canadian adults Background: Neighborhood characteristics are known to be associated with affective health outcomes. However, neighborhoods have rarely been examined as time-varying spaces of ecological exposure.
Objective: To examine how changes in neighborhood material and social deprivation affect distress outcomes in adult Canadians.
Methods: This study examines 2745 participants from Canada's National Population Health Survey, all of whom are urban-and community-dwelling, non-institutionalized adult Canadians (aged 18 and above at baseline in 2000). Participants did not change neighborhood of residence between baseline and follow-up in 2006. Psychological distress was measured at baseline and follow-up using the K6 screening tool. Changes in social and material deprivation were measured using the Pampalon Social and Material Deprivation Index. Associations were analyzed using multivariate linear regressions, controlling for key demographic characteristics, and stratified by baseline deprivation exposure.
Results: At baseline, most participants lived in neighborhoods with low levels of social deprivation, and nearly half of the sample lived in highly materially deprived neighborhoods. Most neighborhoods maintained the same level of social and material deprivation through time. In fully adjusted models, an improvement of social and material settings was associated with a significant increase in distress scores at follow-up. This association remained positive after controlling for baseline distress scores, but the confidence interval shifted slightly to cross the null.
Conclusions: This study suggests that an improvement in neighborhood deprivation, when unplanned and caused by systematically occurring shifts in economic, political, and social environments (i.e. urban gentrification) is associated with worsening psychological distress outcomes. This finding is relevant for urban municipalities, as well as future public health policy.
The psychological effects of gentrification should be explored in more detail in future research. 
Background:
The vulnerability to suicidal behavior has been modeled in deficits in both valuation processes, mediated by ventral prefrontal cortex, and cognitive control processes, associated with dorsal prefrontal cortex.
Objective:
To uncover potential markers of suicidality based on this model, we compared several brain morphometric parameters using magnetic resonance imaging in a large sample and tested their classificatory properties.
Method:
Three groups were recruited: euthymic suicide attempters with a past history of mood disorders and suicidal behaviour (N=67); patient controls with a past history of mood disorders but not suicidal behaviour (N=82); healthy controls without any history of mental disorder (N=82). A theory-driven region-of-interest approach was applied targeting the orbitofrontal cortex (OFC), the anterior cingulate cortex (ACC) and the dorsolateral prefrontal cortex (DLPFC). Both voxel-based (SPM8) and surface-based morphometry (Freesurfer) analyses were used to comprehensively evaluate cortical gray matter signal, volume, surface area and thickness.
Results:
Suicide attempters showed lower signal than controls in bilateral DLPFC (p<0.003) with a very large effect size (Cohen's d=4.8). This measure was correlated with the number of previous suicidal acts and impulsivity trait. Moreover, it improved specificity in detecting suicide attempters when combined with mood disorder status. Contrasts between attempters and patient controls additionally showed large effect sizes (>1) for OFC area, ACC volume, and DLPFC area and thickness. Overall, individuals with histories of suicide attempts show structural deficits independently of mood disorders, which may play a significant role in their vulnerability to suicidal acts. A potential future clinical application of these biomarkers is suggested.
Supported by: fellowship or granting agency. The neurohormone melatonin (MLT) activates two G-protein coupled receptors, MT 1 and MT 2 . MLT is implicated in sleep regulation, however, its role as hypnotic agent still controversial, and the neurobiological mechanism through which it controls the vigilance states has not yet been elucidated. Therefore, the aim was to study the effects of MLT (40 mg/kg) on the 24-h vigilant states by using electroencephalogram and electromyogram in Sprague-Dawley male rats and then to compare these effects with those produced by a non-selective MT 1 /MT 2 receptor agonist (UCM793, 40 mg/kg) and a selective MT 2 receptor partial agonist (UCM924, 40 mg/kg). MLT reduced the latency (+33%) to the first episode of non-rapid eye movement sleep (NREMS) but does not affect the duration of wakefulness, NREMS and rapid eye movement sleep (REMS) during the 24-h sleep-wake cycle. Differently, UCM793 altered the architecture of the awake state increasing its number of episodes (+52%) and decreasing the length of the episodes (-38%) but did not alter the 24-h duration of the three vigilance states. These results corroborate our recent findings in MT 1 /MT 2 receptors knockout mice showing that the modulation of both MT 1 and MT 2 receptors yields no effects on sleep stages because of the selective and opposite role of each MLT receptor subtype on NREMS. Then, UCM924 instead reduced the latency (-56%) and increased (+31%) the duration of NREMS. UCM765 also increased the number of REMS episodes (+57%) without affecting REMS duration. Taken together, these findings show that MLT and non-selective MT1/MT2 receptor agonists do not increase the quantity of sleep but differently influence the three vigilance states. In addition, they support the evidence that selective MT 2 receptor agonists increase NREMS duration compared to MLT and non-selective MT 1 /MT 2 agonists.
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Memory reconsolidation blockade to treat substance dependence: A feasibility study.
Michelle Lonergan, MSc.
DOULGAS MENTAL HEALTH UNIVERSITY INTITUTE, PSYCHOSOCIAL DIVISION; MCGILL UNIVERSITY, DEPARTMENT OF PSYCHIATRY
Background: Conditioned drug-related memories formed during repeated drug using episodes are proposed to underlie craving and the long-term propensity for addicted individuals to relapse, posing a formidable barrier to sustained recovery. Reconsolidation theory suggests that the act of retrieval transiently destabilizes previously consolidate memories, during which time they can be pharmacologically manipulated prior to restabilizing back to long-term storage. Previous literature has revealed that the noradrenergic beta-blocker propranolol can reduce drug-seeking behaviour in rodents and drug craving in humans when administered in conjunction with the retrieval of drug-related memories, opening the door to a novel treatment for addiction. Objective: In a feasibility study, we examined whether memory reconsolidation blockade using propranolol can be successfully implemented in a sample of treatment-seeking individuals with substance dependence. We further explored preliminary treatment effects. Methods: Eligible participants (18-65 years old) were randomized to receive six treatments of memory reconsolidation blockade under propranolol or placebo. Memory reactivation was achieved by having participants read aloud to the investigator a personal drug-using narrative. Outcome measures included evaluating recruitment and retention, the eligibility criteria, protocol adherence, preliminary treatment effects as measured by difference scores on self-report craving severity between the baseline and post-treatment assessments, and rates of relapse. Data Analysis: Feasibility outcomes are reported as counts and percentages. For analysis of treatment effects, missing data was imputed using multiple imputation procedures, and two-tailed independent t-tests were used to examine between-group differences on craving change between baseline and 1-week follow-up. Relapse occurrence was dichotomized and compared between groups. Results: Although comparable to literature examining attrition in clinical trials and addiction treatment programs, we observed a 45% attrition rate. The eligibility criteria and protocol adherence were considered appropriate and adequate. Results from preliminary analyses of treatment effects revealed no significant betweengroup differences on change in subjective craving or relapse during the trial, despite propranolol treated participants tending to demonstrate slightly greater improvement. Conclusion: Despite finding no significant effect of treatment, large multi-center trials of disrupting memory reconsolidation to treat substance dependence are warranted, provided several procedural changes are implemented. The authors discuss ways to address potential methodological pitfalls in future studies. Supported by: fellowship or granting agency.
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Background
Heritability of suicide has been well established in family, twin and adoption studies. Transmission of risk appears to follow vulnerability traits more than co-morbid disorders like depression. Suicide attempters have been found to show cognitive deficits including impaired decision-making and cognitive inhibition.
Objective
In the present project, we aimed at investigating potential cognitive deficits in relatives of suicide completers. We hypothesized that the same cognitive deficits observed in suicide attempters would be found in firstdegree relatives of suicide completers.
Method 17 first-degree relatives of suicide completers without any personal history of suicidal act (RSC) were compared to 18 first-degree relatives of individuals with Major Depressive Disorder but no family history of suicidal act (RMDD), and 19 first-degree relatives of healthy controls (RHC). A large battery of neuropsychological tests was used (National Adult Reading Test, Iowa Gambling Task, Wechsler Adult Intelligence Scale, Trail-Making Test, Stroop, Hayling Sentence Completion Test) evaluating decisionmaking, cognitive inhibition, selective attention, mental flexibility and processing speed.
Results
Preliminary analyses show a trend for poorer decision-making performance in RSC vs. RMDD and RHC. Previous findings have associated this decision-making deficit to an abnormal functioning of the orbitofrontal cortex in suicide attempters compared to non-attempters. Present findings suggest that a similar dysfunction may be found in first-degree RSC. Additional analyses will be conducted soon. These preliminary findings suggest that cognitive deficits, notably disadvantageous decision-making, may represent endophenotypes of suicide. Impairment in cognitive functioning may be a relevant marker of suicidality and the target of future preventative interventions.
Supported by: fellowship or granting agency. Food intake is regulated by a close communication between the homeostatic system in the hypothalamus and the hedonic system (including the mesocorticolimbic pathway). A key region for this communication is the lateral hypothalamus (LH), also known as the "feeding center" of the brain. Both the homeostatic and hedonic systems are still developing during the late fetal and early post-natal periods in the rat, and are known targets for peripheral metabolic hormones such as leptin and ghrelin. Here we examined the onset of leptin and ghrelin responsiveness in the LH, and the activation of cellular signaling molecules in identified neurons on postnatal day (PND) 10 and 16. Leptin significantly activated secondary messengers pERK and pSTAT3 in the LH on PND16, while on PND10, only sparse pSTAT3 cells were identified and the activation of pERK did not reach significance. Double-immunofluorescence staining showed that the majority of pERK-activated neurons are orexin-A (ORX-A) positive neurons. However, leptin-induced pSTAT3 was clearly observed in another population of neurons, potentially neurotensin (NT) neurons. It is unknown whether pERK activation in ORX-A neurons is a direct effect of leptin on ORX-A cells via specific leptin receptors (ObRb), or an indirect activation via leptin-sensitive projections to the ORX-A neurons. Follow-up experiments involving in-situ hybridization of ObRb's with immunohistochemical detection of ORX-A and NT neurons will determine whether ObRb's can be identified on these neurons in the LH during neonatal development. In contrast to leptin responses, ghrelin administration significantly increased Fos activity in ORX-A neurons of the LH on PND10, but the increase over saline injection was not significant on PND16.
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Developmental Responses of the Lateral Hypothalamus to Leptin and Ghrelin in Neontatal Rats
Our results suggest that metabolic hormone responsiveness in the LH is only partially developed prior to the onset of independent feeding on PND16, and that responses to ghrelin might precede those to leptin in this area of the hypothalamus. Furthermore, the maturation of functional connections between the LH and the ventral tegmental area (VTA -a major center of the hedonic system) may play a crucial role in the onset of responsiveness to metabolic hormones and initiation of independent feeding in rat neonates.
Supported by CIHR to CDW.
Illicit and Prescription Opiate Abuse: Understanding Treatment Failure And Improving Outcomes
Kevin Hamdullahpur, Dr. Kathryn Gill
MUHC ADDICTIONS UNIT
Background: Dependence on opiates is a major health issue in North America. The recent increases in both prescription and illicit opiate abuse have exacted enormous tolls in terms of health care, mental illness, quality of life, unemployment, and crime, while the difficulty in treating opioid dependent patients with standard abstinence-based therapies is not well understood. Objectives: The objective of this study was to provide a novel approach to understanding the poor outcomes of opiate dependent patients by focusing on identifying predictors of treatment failure, and by performing qualitative interviews focused on patient treatment experiences. Methods: This study was conducted at the Addictions Unit of the McGill University Health Center in Montreal. Patients were prospectively monitored during inpatient detoxification for opiate dependence or sedative-hypnotic dependence in terms of craving, mood, withdrawal symptoms, vital signs, subjective experiences of pain, and objective measures of hyperalgesia and allodynia. Patient psychiatric comorbidity (Axis I and Axis II disorders), chronic medical conditions (pain syndromes), and severity of substance dependence were also considered. Qualitative interviews were performed following treatment completion to compliment quantitative results and to provide a richer, more comprehensive understanding of the difficulties experienced by patients undergoing detoxification. Results indicated that during treatment patients with cluster B personality disorders reported more negative mood symptoms (anger, anxiety, depression) and greater scores on objective measures of withdrawal. Opiate dependent patients were more likely to have chronic pain conditions, and demonstrate increased physical sensitivity and lower pain thresholds. Together these findings suggest that hyperalgesic, highly sensitive opiate-dependent patients with cluster B personality disorders may have substantial difficulties tolerating both the physical and emotion symptoms of withdrawal, and may benefit from the development of targeted interventions.
CIHR
The Role of Medial Septal Glutamatergic Neurons within the Septum and their Influence on Theta Oscillations in the Hippocampus
Robinson, J., Manseau, F., Williams, S.
WILLIAMS LAB, MCGILL UNIVERSITY
Background: Neurons in the medial septum diagonal band of Broca (MS-DBB) are well known to provide important connections to the hippocampus, and are critical for spatial learning and memory. Three main neuronal populations have been identified in this region: cholinergic, GABAergic and glutamatergic. Glutamate neurons were shown (by Williams's lab) to project to the hippocampus, release glutamate on interneurons and principal cells and to discharge rhythmically at theta frequency. To further explore the role of MS-DBB glutamatergic cells we have used optogenetics to specifically target these neurons.
Objectives:
The first aim of our study has been to determine at the cellular level how glutamate release from MS-DBB neurons can modulate post-synaptic targets within the septum as well as interneurons and principal neurons across the hippocampus. The second aim of the current study has been to determine whether increasing the firing rate of glutamate neurons is sufficient to modulate hippocampal theta oscillations. Methods: To explore the role of MS-DBB glutamatergic neurons we have used optogenetics to specifically target these neurons. We have targeted glutamatergic VGLUT2 neurons of the MS-DBB with the light-sensitive protein channelrhodopsin-2 variant, ChETA. The VGLUT2 CRE-mouse line are injected with a ChETA Cre-recombinase adeno-associated virus to specifically target glutamate neurons of the MS-DBB. Recording techniques used to achieve the specified goals of this study include both patch-clamp and field recordings to either in slice or the entire septo-hippocampal preparation in vitro. Results: By selectively activating this neuronal population, we have obtained large postsynaptic excitatory potentials onto both neurons within the septum as well as to interneurons in CA3 of the hippocampus. In addition, glutamatergic MS-DBB neurons can modulate hippocampal theta rhythm in the whole septo-hippocampal network in vitro, modulating both the power and frequency of theta rhythms. These experiments will provide for the first time an explanation of how medial septum glutamate neurons contribute to hippocampal theta activity. Finally, these results will also provide the background necessary to reinvestigate why medial septum glutamatergic input is critical for learning and memory in freely behaving mice. We are investigating the potential of diminished olfactory identification as a quantitative marker for the progress of pre-symptomatic AD in a longitudinal study of cognitively normal people with a parental history of AD. We have evaluated > 100 people, a majority having at least one follow-up examination. 42% of active participants are enrolled in a protocol of four serial lumbar punctures, and almost all undergo serial MRI scanning, genetic testing, a smell identification testing, and neurocognitive assessment. Results: Preliminary findings show significant association of deficits in cognition (RBANS total index score) and smell identification (UPSIT) (Spearman's r=0.262, p=0.001, n=155). We also note significant correlations between smell identification and bilateral hippocampal volume as well as total ventricular (r=0.238, p=033, n=80; r=-0.299, p=0.007, n=80). Remarkably in a subset of participants, olfactory deficit contribute to a model to predict CSF levels of total tau, 181P-tau and Aβ1-42. Discussion: We are the first to measure an association between CSF biomarkers of AD in living human beings and smell identification. It will be important to assess olfactory sensory processing (and possibly interpretation of other sensory modalities) may serve as a convenient and non-invasive metric of evolving neurodegenerative disease. Recent evidence demonstrates that maternal high-fat consumption during pregnancy and lactation increases the risk of metabolic disorders and obesity in the offspring; however, the underlying mechanisms remain unknown. We previously showed that adult offspring of mothers exposed to a high-fat (HF) diet during the last week of gestation and lactation have altered mesolimbic dopamine (DA) activity, a system that regulates the hedonic value of food. In particular, adult HF offspring display increased tyrosine hydroxylase (TH) activity and reduced D2 receptor expression in the VTA, but the time of onset of these changes is unknown. Here we examined when these changes first appear and whether they are dependent on the post-weaning diet. Contrary to the adult offspring, D2 receptor mRNA expression in the VTA of HF offspring was significantly increased at PND10 and PND16, suggesting that early exposure to high fat could modify the expression of presynaptic D2R in VTA target areas. On PND25, no differences were observed between HF and CD pups. We are currently investigating whether the dynamic regulation of D2R expression in the VTA is dependent upon constant exposure to the HF diet after weaning and are testing offspring during puberty (PND 45) maintained on either a HF or CD diet. In contrast to the increased TH levels observed in the adult HF offspring, pre-weaning HF pups on PND 10 or 16 did not exhibit significant differences in the concentration of TH in the VTA compared to its CD counterpart. To further examine potential early changes in DA synthesis, we are also examining whether the expression of Nurr-1, a transcription factor required for the development of DA cells and upregulation of DA synthesis, is increased in HF rats. Our studies demonstrate that expression of D2R mRNA levels in the VTA is a first and sensitive index of changes occurring in the DA system following exposure to HF diet in the early postnatal period. Increased production of DA in VTA neurons might be upregulated after weaning to a control diet, due to a mismatch between pre-and postweaning diets and compensatory changes induced to maintain adequate dopaminergic function.
